Workboat Indexes
Defence Therapeutics Inc (CSE: DTC )
0.6300
-0.0200
(-3.08%)
Official Closing Price
Updated: 2:05 PM EDT, Aug 27, 2024
Add to My Watchlist
All News about Defence Therapeutics Inc
![](https://pressreach.com/wp-content/uploads/2023/11/image1-5.jpg)
![](https://pressreach.com/wp-content/uploads/2023/11/2355-1.jpg)
![](https://pressreach.com/wp-content/uploads/2023/11/medical-banner-with-doctor-wearing-goggles-1-2.jpg)
Defence Therapeutics Key Platform Patent Accepted Broadly Covering Vaccine Technology
November 07, 2023
Via PressReach
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://pressreach.com/wp-content/uploads/2023/10/Sofiaworld-1.jpg)
Via PressReach
Exposures
Product Safety
![](https://pressreach.com/wp-content/uploads/2023/10/medical-banner-with-doctor-wearing-goggles-1-1.jpg)
Bristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Race
October 17, 2023
Via PressReach
![](https://pressreach.com/wp-content/uploads/2023/10/image1-7.jpg)
Bristol Myers Squibb Joins Big Pharma’s Race to Dominate Oncology
October 17, 2023
Via PressReach
![](https://pressreach.com/wp-content/uploads/2023/10/medicine-doctor-holding-blue-helix-dna-structure-hologram-interface-diagnose-healthcare-3.jpg)
![](https://pressreach.com/wp-content/uploads/2023/10/Angellodeco.jpg)
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
October 10, 2023
Via PressReach
![](https://pressreach.com/wp-content/uploads/2023/10/image1-3.jpg)
Big Pharma’s Billion-Dollar Bets on Advanced Cancer Therapies
October 10, 2023
Via PressReach
Exposures
COVID-19
![](https://pressreach.com/wp-content/uploads/2023/10/Bogdanhoda-2.jpg)
![](https://pressreach.com/wp-content/uploads/2023/09/woman-working-laborator-2.jpg)
Via Newsfile
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.